The influence of metabolic syndrome on the development and clinical manifestations of benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) — one of the most common urological diseases that lead to the development of symptoms of the lower urinary tract (SLUT). BPH-multifactorial disease, in which a significant role is given to increase the activity of the enzyme 5a-reductase and hormonal imbalance asso...
Saved in:
| Main Authors: | V. B. Filimonov, R. V. Vasin, A. A. Kostin, V. N. Panchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2018-12-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/321 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of novel biomarkers of renal dysfunction associated with lower urinary tract symptoms in men with benign prostatic hyperplasia
by: V. Yu. Startsev, et al.
Published: (2024-11-01) -
The clinical signifi cance of urethral sphincter hyperkinesis in the treatment of benign prosta???? c hyperplasia
by: I. I. Belousov
Published: (2019-02-01) -
Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care, Port Harcourt, Nigeria
by: A.A. Bock-Oruma, et al.
Published: (2013-10-01) -
MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
by: Z. M. Akhokhov, et al.
Published: (2023-10-01) -
Urinary dysfunction in patients with unsatisfactory results of surgical treatment of benign prostatic hyperplasia
by: S. Kh. Al-Shukri, et al.
Published: (2017-12-01)